- Home
- DTM vs ASND Comparison
DTM vs ASND Comparison
Compare DTM & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTM
- ASND
- Stock Information
- Founded
- DTM 2021
- ASND 2006
- Country
- DTM United States
- ASND Denmark
- Employees
- DTM N/A
- ASND N/A
- Industry
- DTM Oil & Gas Production
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- DTM Utilities
- ASND Health Care
- Exchange
- DTM Nasdaq
- ASND Nasdaq
- Market Cap
- DTM 11.1B
- ASND 12.2B
- IPO Year
- DTM N/A
- ASND 2015
- Fundamental
- Price
- DTM $114.67
- ASND $218.46
- Analyst Decision
- DTM Buy
- ASND Strong Buy
- Analyst Count
- DTM 12
- ASND 17
- Target Price
- DTM $118.08
- ASND $245.76
- AVG Volume (30 Days)
- DTM 796.6K
- ASND 492.4K
- Earning Date
- DTM 10-30-2025
- ASND 11-12-2025
- Dividend Yield
- DTM 2.86%
- ASND N/A
- EPS Growth
- DTM N/A
- ASND N/A
- EPS
- DTM 3.96
- ASND N/A
- Revenue
- DTM $1,175,000,000.00
- ASND $758,592,045.00
- Revenue This Year
- DTM $27.01
- ASND $104.98
- Revenue Next Year
- DTM $8.91
- ASND $79.91
- P/E Ratio
- DTM $29.00
- ASND N/A
- Revenue Growth
- DTM 20.39
- ASND 97.46
- 52 Week Low
- DTM $83.30
- ASND $118.03
- 52 Week High
- DTM $117.12
- ASND $223.19
- Technical
- Relative Strength Index (RSI)
- DTM 59.10
- ASND 64.35
- Support Level
- DTM $111.55
- ASND $188.07
- Resistance Level
- DTM $115.58
- ASND $202.41
- Average True Range (ATR)
- DTM 2.88
- ASND 9.60
- MACD
- DTM 0.52
- ASND 1.08
- Stochastic Oscillator
- DTM 79.08
- ASND 86.10
About DTM DT Midstream Inc.
DT Midstream Inc is an owner, operator, and developer of natural gas midstream interstate and intrastate pipelines; storage and gathering systems; and compression, treatment, and surface facilities. It provides multiple, integrated natural gas services to customers through interstate pipelines, intrastate pipelines, storage systems, lateral pipelines and related treatment plants and compression and surface facilities, and gathering systems and related treatment plants and compression and surface facilities. The segments of the group are Pipeline and Gathering. It generates revenue from pipeline, storage, and gathering systems, substantially all of which are located in the Midwestern U.S., Eastern Canada, Northeastern U.S., and Gulf Coast regions.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.